Japan-based cell therapy company…
Japan-based cell therapy company Innovacell is planning to end a [...]
Japan-based cell therapy company Innovacell is planning to end a [...]
Six years after the FDA approved Eli Lilly’s Retevmo to [...]
Cyrano Therapeutics is savoring a phase 2 victory. With the [...]
Federal policies under Robert F. Kennedy Jr. that are hostile [...]
Aging means “becoming a target” of the industry, one expert [...]
The FDA has rejected a rare blood disease candidate from [...]
Just as a disciplined soccer player might pass on a [...]
After a string of high-profile regulatory rebukes, Biohaven’s CEO believes [...]
Determined to avoid a repeat of the supply shortfalls that [...]
Friday’s RFI sets a March 19 deadline for stakeholders to [...]